CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 140 enrolled
Drug / intervention
Virtual Realitydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06155669
NCT06155669N/ACompleted
CompareCT.gov

The Impact of Virtual Reality -Guided Visual and Auditory Therapy on Symptom Severity and Psychological Well-Being in Tension-Type Headache Patients: A Controlled Study

Ankara City Hospital Bilkent·interventional·Posted Dec 4, 2023·Updated Jan 15, 2025

In Brief

A clinical study evaluating Virtual Reality for Headache and 2 related conditions. Completed, enrolled 140 participants across 1 site.

Detailed Summary

The primary aim of this research is to objectively assess the impact of virtual reality (VR) technology on pain symptoms in tension-type headache patients. This study is designed to understand the potential of VR in the treatment of tension-type headaches, exploring its ability to reduce pain severity and improve patients' quality of life.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeadache, Analgesia, Tension-Type Headache
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedDec 4, 2023
Enrollment StartDec 15, 2023
Primary CompletionJul 30, 2024
Study CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 2.6 years ago

Interventions

Virtual Realitydevice

Participants will be selected from patients diagnosed with tension-type headache according to the International Classification of Headache Disorders, third edition (ICHD-3) criteria. Selected participants, in addition to being administered 25 mg of dexketoprofen, will also use virtual reality goggles.